JPH0244806B2 - BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU - Google Patents

BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU

Info

Publication number
JPH0244806B2
JPH0244806B2 JP14056381A JP14056381A JPH0244806B2 JP H0244806 B2 JPH0244806 B2 JP H0244806B2 JP 14056381 A JP14056381 A JP 14056381A JP 14056381 A JP14056381 A JP 14056381A JP H0244806 B2 JPH0244806 B2 JP H0244806B2
Authority
JP
Japan
Prior art keywords
vitamin
tocopherol
glyceride
skin
emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP14056381A
Other languages
Japanese (ja)
Other versions
JPS5841813A (en
Inventor
Katsuki Awamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunstar Inc
Original Assignee
Sunstar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunstar Inc filed Critical Sunstar Inc
Priority to JP14056381A priority Critical patent/JPH0244806B2/en
Publication of JPS5841813A publication Critical patent/JPS5841813A/en
Publication of JPH0244806B2 publication Critical patent/JPH0244806B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明はビタミンAを安定に配合した乳化系皮
膚外用剤組成物、さらに詳しくは、ビタミンAを
安定に配合したクリーム、乳液のような皮膚外用
の乳化系医薬製剤、医薬部外品および化粧品に関
する。 従来から、皮膚外用剤の有効成分として各種の
ビタミン類が用いられており、ビタミンAも皮膚
角化症等の予防、治療に有効な成分であることが
知られている。一方、脂溶性ビタミンであるビタ
ミンAは水の非存在下では比較的安定であるが、
水の存在下ではきわめて酸化されやすく、非常に
不安定であることが知られている。 かくして、従来から、乳化系の皮膚外用剤にも
ビタミンAが配合されているが、そのビタミンA
は系中に存在する水のためにきわめて不安定であ
り、経時と共に速やかに酸化されてその効力を失
い、系中に長期にわたつてビタミンAを安定に保
持することが困難である。しかし、かかる乳化系
におけるビタミンAの安定化について、従来、あ
まり検討がなされておらず、未だ乳化系の皮膚外
用剤においてビタミンAを安定に配合できる有効
な手段は見当たらない。 なお、キサンタンガムのような高分子多糖類を
配合してビタミンAの乳化系における安定化を計
ることが提案されているが(特開昭50−82223
号)、高分子多糖類の配合による製品の使用感に
及ぼす影響が問題となる。 このような事情にかんがみ、本発明者は高分子
多糖類を配合しない乳化系の皮膚外用剤における
ビタミンAの安定化について鋭意検討を重ねた。 まず、ビタミンAの配合方法により安定化を図
るべく種々検討したが、安定性の向上は見られな
かつた。つぎに、ビタミンAの酸化を防ぐべく、
各種の抗酸化剤の使用、また、抗酸化剤と、その
シネルギストとして知られるウルトラリン酸、ク
エン酸、アスコルビン酸、ソルビツト、各種アミ
ノ酸との併用を試みたが、かえつて、ビタミンA
の酸化生成物や抗酸化剤、シネルギスト自体に由
来すると考えられる系の著しい着色が生じ、やは
り、充分満足すべき安定性の向上は見られなかつ
た。ところが、意外にも、抗酸化剤としてトコフ
エロールを用いる場合、エチレンジアミン四酢酸
塩(以下、EDTA塩という)および特定の液状
エステル油を併用するとビタミンAの安定性が著
しく向上し、かつ、系の着色という問題も生じな
いことが判明した。 本発明はかかる知見に基づいて完成されたもの
であつて、高分子多糖類を配合しないビタミンA
を有効成分とする乳化系皮膚外用剤組成物におい
て、トコフエロールおよびEDTA塩と、トリカ
プリル酸グリセリド、トリ(2−エチルヘキサン
酸)グリセリド、2−エチルヘキサン酸セチルお
よびジ−(2−エチルヘキサン酸)ネオペンチル
グリコールからなる群から選ばれるエステル油を
配合したことを特徴とするビタミンAを安定に配
合した高分子多糖類無配合乳化系皮膚外用剤組成
物を提供するものである。本発明においては、
EDTA塩も一種の抗酸化剤のシネルギストと考
えられるが、その作用機序は明らかではなく、前
記のごとき従来汎用されるシネルギストと異な
り、系の着色などの問題を生せず、トコフエロー
ルと共にビタミンAの酸化を効果的に防止し、乳
化系の皮膚外用剤に配合されたビタミンAの長期
安定化を図ることができる。 つぎに、乳液に配合したビタミンAに対する各
種のトコフエロール、シネルギストの安定化効果
を試験した結果を示す。 試験方法 後記の処方に従い、ビタミンAパルミテートお
よび各種のトコフエロールおよび/またはシネル
ギストを配合した種々の乳液を調整し、40℃で1
ケ月保存後、各乳液中のビタミンA単位数を定量
し、配合当初のビタミンA単位数に対する残存率
(%)を算出した。また、同時に乳液の着色度合
を肉眼で評価した。
The present invention relates to emulsified external skin preparation compositions containing vitamin A in a stable manner, and more particularly to emulsified pharmaceutical preparations for external use on the skin such as creams and emulsions, quasi-drugs, and cosmetics containing vitamin A in a stable manner. . Conventionally, various vitamins have been used as active ingredients in external skin preparations, and vitamin A is also known to be an effective ingredient in the prevention and treatment of skin keratosis and the like. On the other hand, vitamin A, which is a fat-soluble vitamin, is relatively stable in the absence of water;
It is known to be extremely susceptible to oxidation and extremely unstable in the presence of water. Therefore, vitamin A has traditionally been included in emulsified skin preparations;
Vitamin A is extremely unstable due to the water present in the system, and rapidly oxidizes and loses its effectiveness over time, making it difficult to stably maintain vitamin A in the system over a long period of time. However, the stabilization of vitamin A in such an emulsion system has not been studied much in the past, and no effective means for stably incorporating vitamin A into an emulsion-based skin preparation for external use has yet been found. It has been proposed to stabilize vitamin A in the emulsification system by blending a high-molecular polysaccharide such as xanthan gum (Japanese Patent Laid-Open No. 50-82223).
(No.), the effect of the combination of high-molecular polysaccharides on the feel of the product is a problem. In view of these circumstances, the present inventors have conducted extensive studies on stabilizing vitamin A in emulsified external skin preparations that do not contain polymeric polysaccharides. First, various studies were conducted to stabilize the product by changing the method of blending vitamin A, but no improvement in stability was observed. Next, in order to prevent the oxidation of vitamin A,
We have tried using various antioxidants and combining antioxidants with synergists such as ultraphosphoric acid, citric acid, ascorbic acid, sorbitol, and various amino acids, but on the contrary, vitamin A
Significant coloring of the system occurred, which was thought to be due to the oxidation products of the compound, the antioxidant, and the synergist itself, and no sufficiently satisfactory improvement in stability was observed. However, surprisingly, when using tocopherol as an antioxidant, the stability of vitamin A is significantly improved when ethylenediaminetetraacetate (hereinafter referred to as EDTA salt) and a specific liquid ester oil are used together, and the coloring of the system is significantly improved. It turns out that this problem does not arise. The present invention has been completed based on this knowledge, and provides vitamin A that does not contain polymeric polysaccharides.
In the emulsified skin external preparation composition containing as active ingredients, tocopherol and EDTA salt, tricaprylic acid glyceride, tri(2-ethylhexanoic acid) glyceride, cetyl 2-ethylhexanoate, and di-(2-ethylhexanoic acid) To provide an emulsified skin external preparation composition that is stably blended with vitamin A and is free of polymeric polysaccharides, characterized in that it contains an ester oil selected from the group consisting of neopentyl glycol. In the present invention,
EDTA salt is also considered to be a type of antioxidant synergist, but its mechanism of action is not clear.Unlike the conventionally used synergists mentioned above, it does not cause problems such as coloring of the system, and it is effective against vitamin A along with tocopherol. It is possible to effectively prevent the oxidation of vitamin A and achieve long-term stabilization of vitamin A contained in emulsified skin preparations. Next, the results of testing the stabilizing effects of various tocopherols and synergists on vitamin A blended into emulsion are shown. Test method Various emulsions containing vitamin A palmitate and various tocopherols and/or sinergists were prepared according to the formulations below, and the emulsions were heated at 40℃ for 1
After storage for several months, the number of vitamin A units in each emulsion was determined, and the residual rate (%) relative to the initial number of vitamin A units was calculated. At the same time, the degree of coloring of the emulsion was visually evaluated.

【表】 水 〓 残部
香料 適量
この処方に従い、Aの各成分を混合し、約75℃
で加温溶解し、これを、約75℃に加温したBの各
成分混合物に加え、よく撹拌し、冷却し、ついで
香料を加えて乳液を得た。 ビタミンAパルミテートの定量はつぎのとおり
行なつた。 乳液試料約10gを精秤し、クロロホルム−エタ
ノール(1:1)混液約80mlに溶解した。これを
濾過し、同じ混液で希釈して100mlとし、試料溶
液として用いた。 別途、あらかじめビタミンA単位数を測定した
ビタミンAパルミテート標準品約10mgを精秤し、
クロロホロム−エタノール(1:1)混液で100
mlとし、これを標準溶液として用いた。 これらの試料溶液および標準溶液を、各々、
20μのループ式計量管に注入し、高速液体クロ
マトグラフイーに付した(島津製作所製、高速液
体クロマト装置LC−1、カラム:ヌクレオシル
C−18(28cm×φ4mm)、移動相:メタノール、カ
ラム温度:35℃、流速:1.0ml/分、検出波長:
320nm)。得られたクロマトグラム中のビタミン
Aパルミテートのピーク高さを測定し、試料溶液
のピーク高さをAt、標準溶液のピーク高さをAs
とし、次式に従つて試料溶液中のビタミンA単位
数を求めた。 試料溶液中のビタミン単位数=ビタミンAパルミテート
標準品1gの単位数 ×ビタミンAパルミテート標準品秤取量mg×1/1000
×At/As 結果をつぎの第1表に示す。なお、対照として
トコフエロール、シネルギスト無添加の乳液につ
いて同様に試験した結果も示す。また、第1表中
における着色はつぎの基準に従つて評価した。 ○:着色なし △:やや着色気味 ×:着色 ××:ややひどい着色 ×××:ひどい着色 ××××:非常に着色
[Table] Water = Remainder
Fragrance (appropriate amount)
According to this recipe, mix each component of A at about 75℃.
This was added to the mixture of each component of B heated to about 75°C, stirred well, cooled, and then a fragrance was added to obtain a milky lotion. Quantification of vitamin A palmitate was carried out as follows. Approximately 10 g of the emulsion sample was accurately weighed and dissolved in approximately 80 ml of a chloroform-ethanol (1:1) mixture. This was filtered, diluted with the same mixture to make 100 ml, and used as a sample solution. Separately, accurately weigh out approximately 10 mg of a standard vitamin A palmitate product whose number of vitamin A units has been measured in advance.
100 with chloroform-ethanol (1:1) mixture
ml, and this was used as a standard solution. These sample solutions and standard solutions, respectively,
It was injected into a 20 μ loop measuring tube and subjected to high performance liquid chromatography (Shimadzu Corporation, high performance liquid chromatography device LC-1, column: Nucleosil C-18 (28 cm x φ4 mm), mobile phase: methanol, column temperature. : 35℃, flow rate: 1.0ml/min, detection wavelength:
320nm). Measure the peak height of vitamin A palmitate in the obtained chromatogram, and define the peak height of the sample solution as At and the peak height of the standard solution as As.
The number of vitamin A units in the sample solution was determined according to the following formula. Number of vitamin units in the sample solution = Number of units in 1 g of vitamin A palmitate standard product × Weighed amount of vitamin A palmitate standard product mg × 1/1000
×At/As The results are shown in Table 1 below. In addition, as a control, the results of a similar test on an emulsion without tocopherol or synergist are also shown. Moreover, the coloring in Table 1 was evaluated according to the following criteria. ○: Not colored △: Slightly colored ×: Colored ××: Slightly colored ×××: Severely colored ××××: Very colored

【表】【table】

【表】 第1表に示すごとく、EDTA塩とトコフエロ
ールを併用した場合のみ、40℃、1ケ月の保存の
後にも着色を起すことなく、70%以上もの高いビ
タミンA残存率を保持することができる。 また、前記の乳液処方に天然ビタミンEもしく
はδ−トコフエロール0.05%、EDTA・2Na0.02
%を配合し、かつ、イソプロピルミリステート
1.0%の代わりに、種々の油脂成分を加えて調製
した乳液のビタミンA残存率(%)および着色を
同様に評価した。結果を第2表および第3表に示
す。
[Table] As shown in Table 1, only when EDTA salt and tocopherol are used together, a high vitamin A residual rate of over 70% can be maintained without coloring even after storage at 40℃ for one month. can. In addition, the above emulsion formula contains natural vitamin E or δ-tocopherol 0.05%, EDTA/2Na 0.02
% and isopropyl myristate
The vitamin A residual rate (%) and coloring of emulsions prepared by adding various oil and fat components instead of 1.0% were similarly evaluated. The results are shown in Tables 2 and 3.

【表】【table】

【表】【table】

【表】【table】

【表】 第2表および第3表に示すごとく、前記のエス
テル油を併用すると、ビタミンAが著しく安定化
される。 かくして、本発明の皮膚外用剤組成物はO/W
型、W/O型いずれの乳化系でもよく、有効成分
としてビタミンAを配合し、トコフエロールおよ
びEDTA塩の併用および該エステル油の油相へ
の配合によりその安定化を図るものである。 用いるビタミンAとしては、ビタミンAパルミ
テート、ビタミンAアセテート等、通常のこの種
組成物に配合されるものいずれでもよく、配合量
は実際の組成物の剤形、所望の薬効等により適宜
選択できるが、一般に、組成物全量に対して0.01
〜0.5%(重量%、以下同じ)程度が好ましい。 トコフエロールには種々の異性体であるが、本
発明においては特に限定するものではなく、d、
l、dl−体いずれでもよく、また、α、β、γ、
δ−体いずれでもよい。さらに、これらの混合物
やトコフエロールの混合物として知られるビタミ
ンEなども用いることができる。なお、トコフエ
ロールと他の抗酸化剤を組合せると、かえつて酸
化を促進するので、そのような抗酸化剤の混合使
用はさけるべきである。トコフエロールの配合量
も適宜選択できるが、一般に、組成物全量に対し
て0.001〜0.5%程度が望ましい。 EDTA塩としては、EDTA−1ナトリウム、
EDTA−2ナトリウム、EDTA−3ナトリウム、
EDTA−4ナトリウムなどが用いられ、通常、
組成物全量に対して0.001〜0.5%程度が望まし
い。 該エステル油は通常、20%程度までの量で用い
られ、これより多量に用いてもよいが、前記第2
表および第3表から明らかなごとく、それ以上の
ビタミンAの安定化効果の向上は期待できない。 本発明の皮膚外用剤組成物は、常法に従つて、
乳液、クリーム、エアゾール、パツクのような乳
化系の剤形の医薬製剤、医薬部外品、化粧品に調
製することができ、他の配合成分は特に限定する
ものではなく、通常用いられるものいずれでもよ
い。 つぎに実施例を挙げて本発明をさらに詳しく説
明する。 実施例 1
[Table] As shown in Tables 2 and 3, when the above-mentioned ester oil is used in combination, vitamin A is significantly stabilized. Thus, the skin external preparation composition of the present invention is O/W.
Either type or W/O type emulsification system may be used, and vitamin A is blended as an active ingredient, and stabilization is attempted by combining tocopherol and EDTA salt and blending the ester oil into the oil phase. The vitamin A to be used may be any of those commonly incorporated into this type of composition, such as vitamin A palmitate and vitamin A acetate, and the amount to be added can be selected as appropriate depending on the actual dosage form of the composition, desired medicinal efficacy, etc. , generally 0.01 based on the total composition
It is preferably about 0.5% (weight %, the same applies hereinafter). There are various isomers of tocopherols, but in the present invention, they are not particularly limited, and include d,
Either l or dl-forms may be used, and α, β, γ,
Any δ-isomer may be used. Furthermore, mixtures of these and vitamin E, which is known as a mixture of tocopherols, can also be used. Note that combining tocopherols with other antioxidants will actually promote oxidation, so mixed use of such antioxidants should be avoided. Although the amount of tocopherol to be added can be selected as appropriate, it is generally desired to be about 0.001 to 0.5% based on the total amount of the composition. EDTA salts include EDTA-1 sodium,
EDTA-disodium, EDTA-trisodium,
EDTA-4 sodium etc. are used, and usually
It is preferably about 0.001 to 0.5% based on the total amount of the composition. The ester oil is usually used in an amount up to about 20%, and may be used in a larger amount, but the second
As is clear from the table and Table 3, no further improvement in the stabilizing effect of vitamin A can be expected. The skin external preparation composition of the present invention can be prepared according to a conventional method.
It can be prepared into pharmaceutical preparations, quasi-drugs, and cosmetics in the form of emulsions such as emulsions, creams, aerosols, and packs, and other ingredients are not particularly limited, and any commonly used ingredients can be used. good. Next, the present invention will be explained in more detail with reference to Examples. Example 1

【表】 香料 適量
この処方に従い、Aの各成分を混合し、約75℃
で加温溶解し、これを、約75℃に加温したBの各
成分混合物に加え、よく撹拌し、冷却し、ついで
香料を加えてビタミンAを安定に配合した乳液を
得た。 実施例 2
[Table] Appropriate amount of fragrance
According to this recipe, mix each component of A at about 75℃.
This was added to the mixture of each component of B heated to about 75° C., stirred well, cooled, and then a fragrance was added to obtain an emulsion in which vitamin A was stably blended. Example 2

【表】 香料 適量
この処方に従い、前記実施例1と同様にしてビ
タミンAを安定に配合したコールドクリームを得
た。
[Table] Appropriate amount of fragrance
According to this formulation, a cold cream stably containing vitamin A was obtained in the same manner as in Example 1 above.

Claims (1)

【特許請求の範囲】[Claims] 1 高分子多糖類を配合しないビタミンA配合乳
化系皮膚外用剤組成物において、トコフエロール
およびエチレンジアミン四酢酸塩と、トリカプリ
ル酸グリセリド、トリ(2−エチルヘキサン酸)
グリセリド、2−エチルヘキサン酸セチルおよび
ジ−(2−エチルヘキサン酸)ネオペンチルグリ
コールからなる群から選ばれるエステル油を配合
したことを特徴とするビタミンAを安定に配合し
た高分子多糖類無配合乳化系皮膚外用剤組成物。
1. In a vitamin A-containing external skin preparation composition containing no polymeric polysaccharide, tocopherol and ethylenediaminetetraacetate, tricaprylic acid glyceride, tri(2-ethylhexanoic acid)
Contains an ester oil selected from the group consisting of glyceride, cetyl 2-ethylhexanoate, and neopentyl di-(2-ethylhexanoate) Glyceride Stable blend of vitamin A, free of polymeric polysaccharides Emulsified skin external preparation composition.
JP14056381A 1981-09-07 1981-09-07 BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU Expired - Lifetime JPH0244806B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14056381A JPH0244806B2 (en) 1981-09-07 1981-09-07 BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14056381A JPH0244806B2 (en) 1981-09-07 1981-09-07 BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU

Publications (2)

Publication Number Publication Date
JPS5841813A JPS5841813A (en) 1983-03-11
JPH0244806B2 true JPH0244806B2 (en) 1990-10-05

Family

ID=15271586

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14056381A Expired - Lifetime JPH0244806B2 (en) 1981-09-07 1981-09-07 BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU

Country Status (1)

Country Link
JP (1) JPH0244806B2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60246306A (en) * 1984-05-22 1985-12-06 Shiseido Co Ltd Water-in-oil type emulsified cosmetic
JPS60246307A (en) * 1984-05-22 1985-12-06 Shiseido Co Ltd Oil-in-water type emulsified cosmetic
CA1282326C (en) * 1984-12-14 1991-04-02 Paul J. Jarosz Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient
US5559149A (en) 1990-01-29 1996-09-24 Johnson & Johnson Consumer Products, Inc. Skin care compositions containing retinoids
US5583136A (en) * 1990-01-29 1996-12-10 Johnson & Johnson Consumer Products, Inc. Retinoid containing skin care compositions containing imidazoles
WO1994001074A1 (en) * 1992-07-13 1994-01-20 Shiseido Company, Ltd. Composition for dermatologic preparation
US6461622B2 (en) 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
JPH1053515A (en) * 1996-08-09 1998-02-24 Ajinomoto Co Inc Skin lotion
US6531141B1 (en) 2000-03-07 2003-03-11 Ortho-Mcneil Pharmaceutical, Inc. Oil-in-water emulsion containing tretinoin
JP5108178B2 (en) * 2001-02-16 2012-12-26 花王株式会社 Packaged product and adsorption prevention method
JP4119296B2 (en) * 2003-04-14 2008-07-16 株式会社コーセー Cosmetics
US20050042306A1 (en) * 2003-08-21 2005-02-24 Christopher Marrs Stabilized compositions containing an oxygen-labile active agent
JP5044106B2 (en) * 2005-05-20 2012-10-10 Basfジャパン株式会社 Aerosol composition for human body containing vitamins
JP5902410B2 (en) * 2010-07-16 2016-04-13 ロート製薬株式会社 Composition for external use

Also Published As

Publication number Publication date
JPS5841813A (en) 1983-03-11

Similar Documents

Publication Publication Date Title
KR930007911B1 (en) External preparations free of discoloration
KR100309399B1 (en) Preparation for epidermis
US5023235A (en) Antioxidant system based on an ascorbyl ester in combination with a complexing agent and a thiol and to compositions containing the same
US4818521A (en) Emulsion cosmetic stably containing vitamin C
JP3103430B2 (en) Fat-soluble antioxidant mixture
US5114716A (en) Anti-oxidant system containing stabilized ascorbyl ester, tocopherol or cafeic acid or a derivative thereof, a complexing agent and a polypeptide, and compositions containing the anti-oxidant system
ES2212344T3 (en) STABLE COMPOSITIONS CONTAINING BIOLOGICALLY ACTIVE COMPONENTS.
JPH0244806B2 (en) BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU
JPH05271048A (en) Cosmetics and pharmaceutical composition
JPH0751491B2 (en) Emulsified cosmetics containing crude drugs
US6124274A (en) Use of ascorbyl 2'-phosphates for stabilizing vitamin A and/or vitamin A derivatives in cosmetic and pharmaceutical preparations
JP2822093B2 (en) W / O / W type emulsified cosmetic
KR100297347B1 (en) A W/O type emulsion cosmetic composition containing the stabilized L-ascorbic acid and a method for preparing the same
JPS61130232A (en) Shikonin-containing composition
JPS6245202B2 (en)
JP2663136B2 (en) Whitening cosmetics
JPH11335284A (en) Retinoid-containing skin lotion
JPS6256411A (en) Beautifying agent
US5378453A (en) Composition for preventing graying of the hair and restoring grayed hair to its natural color
JPH1017436A (en) Skin preparation for external use
JP2906269B2 (en) External preparation for skin
CN114828839A (en) Vitamin A and vitamin C combinations with enhanced stability
JP3421071B2 (en) External preparation containing oil-soluble licorice extract
JPH0812532A (en) Hair-raising agent
JPH1046142A (en) Antioxidant